Stocks Health care CPHI

NYSE · Health care

China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings, Inc. brought in $3.9M of revenue over the twelve months to June 30, 2026, down 11.0% from a year earlier. It posted a net loss of $4.5M. Operating cash flow minus capital spending left $88.9K of free cash flow in fiscal 2025. At June 30, 2026 it held $304.9K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

What China Pharma Holdings, Inc. does

China Pharma Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker CPHI.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where CPHI ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What China Pharma Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 14, 2026
   Quarterly report 10-Q · period to June 30, 2026
2. July 23, 2026
   Securities offering prospectus 424B5
3. July 22, 2026
   Material agreement 8-K
4. May 15, 2026
   Quarterly report 10-Q · period to March 31, 2026
5. April 1, 2026
   Annual report 10-K · period to December 31, 2025
6. April 1, 2026
   Late annual report notice NT 10-K
7. March 3, 2026
   Material agreement 8-K
8. February 10, 2026
   Material agreement 8-K
9. January 6, 2026
   Shareholder vote results 8-K
10. December 23, 2025
    Material agreement 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on January 26, 2024. Insider transactions on SEC

What is CPHI worth? A DCF from its reported cash flow

Insider trades

What the people running China Pharma Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about CPHI

What does China Pharma Holdings, Inc. do?

China Pharma Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker CPHI.

Is China Pharma Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $4.5M on revenue of $3.9M.

How much revenue does China Pharma Holdings, Inc. make?

Over the twelve months to June 30, 2026 China Pharma Holdings, Inc. reported revenue of $3.9M. That is 11.0% less than a year earlier.

When did China Pharma Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.

Similar companies

Compare CPHI with

Compare CPHI with any company

Follow CPHI

Get an email when China Pharma Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CPHI: get an email when it files

Where the numbers come from

Financial figures are the values China Pharma Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.